{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T02:46:08Z","timestamp":1788403568332,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T00:00:00Z","timestamp":1568160000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T00:00:00Z","timestamp":1568160000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HI15C2632"],"award-info":[{"award-number":["HI15C2632"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["2015M3C9A2054342"],"award-info":[{"award-number":["2015M3C9A2054342"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Although immunoglobulin A nephropathy (IgAN) is associated with an increased risk of renal allograft failure, evidences for its treatment, including renin-angiotensin-aldosterone system blockade (RAASB) usage, remain limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this bi-center retrospective cohort study, we included patients who were recently diagnosed with IgAN through allograft biopsies. We identified their 6-month antihypertensive medication prescriptions and investigated the association between the medication types, albuminuria changes, and risk of 5-year death-censored-graft-failure (DCGF). The mixed effect model and cox regression analysis were used.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 464 allograft IgAN patients were included: 272, 38, 33, and 121 patients in the no antihypertensive medication, single agent RAASB, single agent beta blocker (BB)\/calcium channel blocker (CCB), and combination therapy groups, respectively. High-degree albuminuria after 6\u2009months of allograft IgAN diagnosis was an important prognostic parameter and a partial mediator for the association between the subgroups and 5-year DCGF. The usage of single RAASB was associated with decrement of albuminuria from allograft IgAN\u00a0diagnosis (\n                      <jats:italic>P<\/jats:italic>\n                      for interaction\u2009=\u20090.03). The single BB\/CCB group demonstrated significantly worse prognosis than the single RAASB group (adjusted hazard ratio, 2.76 [1.09\u20136.98];\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.03).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In conclusion, RAASB may be beneficial for graft prognosis in early allograft IgAN patients who require single antihypertensive medication therapy, by means of reducing albuminuria. Further investigation of treatment strategy in allograft IgAN is warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-019-1537-1","type":"journal-article","created":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T02:53:33Z","timestamp":1568170413000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Possible beneficial association between renin-angiotensin-aldosterone-system blockade usage and graft prognosis in allograft IgA nephropathy: a retrospective cohort study"],"prefix":"10.1186","volume":"20","author":[{"given":"Sehoon","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung Hee","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heounjeong","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang\u2013il","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jongwon","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Chul","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Pyo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yon Su","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Chul","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Kil","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1873-1587","authenticated-orcid":false,"given":"Hajeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,11]]},"reference":[{"issue":"8","key":"1537_CR1","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1038\/sj.ki.5000292","volume":"69","author":"R Nair","year":"2006","unstructured":"Nair R, Walker PD. Is IgA nephropathy the commonest primary glomerulopathy among young adults in the USA? Kidney Int. 2006;69(8):1455\u20138.","journal-title":"Kidney Int"},{"issue":"1","key":"1537_CR2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1159\/000345960","volume":"37","author":"H Lee","year":"2013","unstructured":"Lee H, Kim DK, Oh KH, Joo KW, Kim YS, Chae DW, Kim S, Chin HJ. Mortality and renal outcome of primary glomerulonephritis in Korea: observation in 1,943 biopsied cases. Am J Nephrol. 2013;37(1):74\u201383.","journal-title":"Am J Nephrol"},{"issue":"6","key":"1537_CR3","doi-asserted-by":"publisher","first-page":"301","DOI":"10.5500\/wjt.v7.i6.301","volume":"7","author":"F Abbas","year":"2017","unstructured":"Abbas F, El Kossi M, Jin JK, Sharma A, Halawa A. Recurrence of primary glomerulonephritis: review of the current evidence. World J Transplant. 2017;7(6):301\u201316.","journal-title":"World J Transplant"},{"issue":"9","key":"1537_CR4","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1097\/TP.0000000000001093","volume":"100","author":"ML Wyld","year":"2016","unstructured":"Wyld ML, Chadban SJ. Recurrent IgA nephropathy after kidney transplantation. Transplantation. 2016;100(9):1827\u201332.","journal-title":"Transplantation"},{"issue":"2","key":"1537_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1056\/NEJMoa013036","volume":"347","author":"EM Briganti","year":"2002","unstructured":"Briganti EM, Russ GR, McNeil JJ, Atkins RC, Chadban SJ. Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med. 2002;347(2):103\u20139.","journal-title":"N Engl J Med"},{"issue":"2","key":"1537_CR6","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.kint.2017.03.015","volume":"92","author":"PJ Allen","year":"2017","unstructured":"Allen PJ, Chadban SJ, Craig JC, Lim WH, Allen RDM, Clayton PA, Teixeira-Pinto A, Wong G. Recurrent glomerulonephritis after kidney transplantation: risk factors and allograft outcomes. Kidney Int. 2017;92(2):461\u20139.","journal-title":"Kidney Int"},{"issue":"2","key":"1537_CR7","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1432-2277.2009.00966.x","volume":"23","author":"SS Han","year":"2010","unstructured":"Han SS, Huh W, Park SK, Ahn C, Han JS, Kim S, Kim YS. Impact of recurrent disease and chronic allograft nephropathy on the long-term allograft outcome in patients with IgA nephropathy. Transpl Int. 2010;23(2):169\u201375.","journal-title":"Transpl Int"},{"issue":"1","key":"1537_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/ajt.14908","volume":"19","author":"S Park","year":"2019","unstructured":"Park S, Baek CH, Cho H, Yu MY, Kim YC, Go H, Kim YH, Lee JP, Min SI, Ha J, et al. Glomerular crescents are associated with worse graft outcome in allograft IgA nephropathy. Am J Transplant. 2019;19(1):145\u201355.","journal-title":"Am J Transplant"},{"issue":"6","key":"1537_CR9","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1681\/ASN.2006040347","volume":"18","author":"R Coppo","year":"2007","unstructured":"Coppo R, Peruzzi L, Amore A, Piccoli A, Cochat P, Stone R, Kirschstein M, Linne T. IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria. J Am Soc Nephrol. 2007;18(6):1880\u20138.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"1537_CR10","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1097\/01.ASN.0000068460.37369.DC","volume":"14","author":"M Praga","year":"2003","unstructured":"Praga M, Gutierrez E, Gonzalez E, Morales E, Hernandez E. Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial. J Am Soc Nephrol. 2003;14(6):1578\u201383.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"1537_CR11","first-page":"265","volume":"9","author":"G Maschio","year":"1994","unstructured":"Maschio G, Cagnoli L, Claroni F, Fusaroli M, Rugiu C, Sanna G, Sasdelli M, Zuccala A, Zucchelli P. ACE inhibition reduces proteinuria in normotensive patients with IgA nephropathy: a multicentre, randomized, placebo-controlled study. Nephrol Dial Transplant. 1994;9(3):265\u20139.","journal-title":"Nephrol Dial Transplant"},{"key":"1537_CR12","first-page":"1):1","volume":"3","author":"KDIGO work group","year":"2013","unstructured":"KDIGO work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1):1\u2013150.","journal-title":"Kidney Int Suppl"},{"issue":"1","key":"1537_CR13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1053\/j.ajkd.2016.08.018","volume":"69","author":"S Hiremath","year":"2017","unstructured":"Hiremath S, Fergusson DA, Fergusson N, Bennett A, Knoll GA. Renin-angiotensin system blockade and long-term clinical outcomes in kidney transplant recipients: a meta-analysis of randomized controlled trials. Am J Kidney Dis. 2017;69(1):78\u201386.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"1537_CR14","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/j.1432-2277.2008.00638.x","volume":"21","author":"JM Cruzado","year":"2008","unstructured":"Cruzado JM, Rico J, Grinyo JM. The renin angiotensin system blockade in kidney transplantation: pros and cons. Transpl Int. 2008;21(4):304\u201313.","journal-title":"Transpl Int"},{"issue":"11","key":"1537_CR15","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1681\/ASN.2006050543","volume":"17","author":"G Opelz","year":"2006","unstructured":"Opelz G, Zeier M, Laux G, Morath C, Dohler B. No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a collaborative transplant study report. J Am Soc Nephrol. 2006;17(11):3257\u201362.","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"1537_CR16","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1111\/j.1600-6143.2007.01928.x","volume":"7","author":"S Hiremath","year":"2007","unstructured":"Hiremath S, Fergusson D, Doucette S, Mulay AV, Knoll GA. Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence. Am J Transplant. 2007;7(10):2350\u201360.","journal-title":"Am J Transplant"},{"issue":"5","key":"1537_CR17","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1093\/ndt\/15.5.689","volume":"15","author":"K Oka","year":"2000","unstructured":"Oka K, Imai E, Moriyama T, Akagi Y, Ando A, Hori M, Okuyama A, Toki K, Kyo M, Kokado Y, et al. A clinicopathological study of IgA nephropathy in renal transplant recipients: beneficial effect of angiotensin-converting enzyme inhibitor. Nephrol Dial Transplant. 2000;15(5):689\u201395.","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"1537_CR18","doi-asserted-by":"publisher","first-page":"3550","DOI":"10.1093\/ndt\/gfl506","volume":"21","author":"AE Courtney","year":"2006","unstructured":"Courtney AE, McNamee PT, Nelson WE, Maxwell AP. Does angiotensin blockade influence graft outcome in renal transplant recipients with IgA nephropathy? Nephrol Dial Transplant. 2006;21(12):3550\u20134.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"1537_CR19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/ki.2009.377","volume":"77","author":"BL Kasiske","year":"2010","unstructured":"Kasiske BL, Zeier MG, Chapman JR, Craig JC, Ekberg H, Garvey CA, Green MD, Jha V, Josephson MA, Kiberd BA, et al. KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int. 2010;77(4):299\u2013311.","journal-title":"Kidney Int"},{"key":"1537_CR20","doi-asserted-by":"crossref","unstructured":"Park S, Go H, Baek CH, Kim YH, Kim YC, Yang SH, Lee JP, Min SI, Ha J, Song EY, et al. Clinical importance of the updated Oxford classification in allograft IgA nephropathy. Am J Transplant. 2019; Epub ahead of print.","DOI":"10.1111\/ajt.15400"},{"issue":"5","key":"1537_CR21","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1053\/j.ajkd.2005.02.012","volume":"45","author":"M Constantiner","year":"2005","unstructured":"Constantiner M, Sehgal AR, Humbert L, Constantiner D, Arce L, Sedor JR, Schelling JR. A dipstick protein and specific gravity algorithm accurately predicts pathological proteinuria. Am J Kidney Dis. 2005;45(5):833\u201341.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"1537_CR22","first-page":"1","volume":"59","author":"TY Dustin Tingley","year":"2014","unstructured":"Dustin Tingley TY, Hirose K, Keele L, Imai K. Mediation: R package for causal mediation analysis. J Stat Softw. 2014;59(5):1\u201338.","journal-title":"J Stat Softw"},{"key":"1537_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v045.i03","volume":"45","author":"SVG-OK Buuren","year":"2011","unstructured":"Buuren SVG-OK. Mice: multivariate imputation by chained equations in R. J Stat Softw. 2011;45:1\u201367.","journal-title":"J Stat Softw"},{"issue":"20","key":"1537_CR24","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","volume":"329","author":"EJ Lewis","year":"1993","unstructured":"Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The collaborative study group. N Engl J Med. 1993;329(20):1456\u201362.","journal-title":"N Engl J Med"},{"issue":"9069","key":"1537_CR25","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/S0140-6736(96)11445-8","volume":"349","author":"The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)","year":"1997","unstructured":"The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet. 1997;349(9069):1857\u201363.","journal-title":"Lancet"},{"issue":"12","key":"1537_CR26","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1111\/j.1600-6143.2007.02006.x","volume":"7","author":"H Amer","year":"2007","unstructured":"Amer H, Fidler ME, Myslak M, Morales P, Kremers WK, Larson TS, Stegall MD, Cosio FG. Proteinuria after kidney transplantation, relationship to allograft histology and survival. Am J Transplant. 2007;7(12):2748\u201356.","journal-title":"Am J Transplant"},{"issue":"3","key":"1537_CR27","first-page":"1537","volume":"28","author":"N Kimata","year":"1996","unstructured":"Kimata N, Tanabe K, Ishikawa N, Ozu H, Sonda K, Yumura W, Toma H, Nihei H, Ota K, Takahashi K. Correlation between proteinuria and prognosis of transplant IgA nephropathy. Transplant Proc. 1996;28(3):1537\u20139.","journal-title":"Transplant Proc"},{"issue":"6","key":"1537_CR28","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1097\/00007890-199709270-00021","volume":"64","author":"LF Morrone","year":"1997","unstructured":"Morrone LF, Di Paolo S, Logoluso F, Schena A, Stallone G, Giorgino F, Schena FP. Interference of angiotensin-converting enzyme inhibitors on erythropoiesis in kidney transplant recipients: role of growth factors and cytokines. Transplantation. 1997;64(6):913\u20138.","journal-title":"Transplantation"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1537-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-019-1537-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1537-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T13:01:30Z","timestamp":1599742890000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-019-1537-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,11]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1537"],"URL":"https:\/\/doi.org\/10.1186\/s12882-019-1537-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.10961\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.10961\/v2","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,11]]},"assertion":[{"value":"9 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the institutional review board (IRB) of Seoul National University Hospital (SNUH, IRB No: H-1701-008-819) and Asan Medical Center (AMC, IRB No: S2017\u20130369-0001). We performed this study in accordance with the principles of the Declaration of Helsinki. Informed consent was waived under approval by the attending IRB because of the retrospective nature of the study. The clinical and research activities being reported are consistent with the Principles of the Declaration of Istanbul as outlined in the \u2018Declaration of Istanbul on Organ Trafficking and Transplant Tourism\u2019.\"","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"354"}}